Antioxidant activity of new ruthenium compounds

Redox Rep. 2005;10(3):139-43. doi: 10.1179/135100005X38897.

Abstract

Many biological properties have been attributed to ruthenium complexes including anti-tumor activity and the attenuation of reperfusion damage and infarct size. In this work, we characterize the antioxidant activity of trans-[RuCl2(nic)4] where nic is 3-pyridinecarboxylic acid and trans-[RuCl2(i-nic)4] where i-nic is 4-pyridinecarboxylic acid by (i) evaluation of total antioxidant potential (TRAP); (ii) prevention of DNA damage induced by hydrogen peroxide using the alkaline comet assay; and (iii) the prevention of lipid peroxidation and cell death induced by iron in liver slices. Our results suggest that nic has stronger antioxidant potential when compared to the i-nic. Higher doses (above 200 microM) of these compounds gave genotoxic effects, but the antioxidant potential could be obtained with the use lower doses (0.1-10 microM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antioxidants / metabolism
  • Antioxidants / pharmacology*
  • Comet Assay
  • DNA Damage
  • Isonicotinic Acids / pharmacology
  • Lipid Peroxidation
  • Liver / metabolism
  • Niacin / pharmacology
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Ruthenium / pharmacology*
  • Ruthenium Compounds / pharmacology*

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Isonicotinic Acids
  • Ruthenium Compounds
  • Niacin
  • Ruthenium